Literature DB >> 15798953

Serum resistin level among healthy subjects: relationship to anthropometric and metabolic parameters.

Ching-Chu Chen1, Tsai-Chung Li, Chia-Ing Li, Chiu-Shong Liu, Hui-Ju Wang, Cheng-Chieh Lin.   

Abstract

Resistin is a novel adipocyte-secreted hormone that has been proposed to be the link between obesity and diabetes, although little appears to be known regarding the physiological role of resistin in human beings. We aimed to explore the relationship between serum resistin level and certain anthropometric and metabolic parameters. Seventy-one healthy subjects with a mean body mass index of 23 kg/m 2 or greater were recruited in this study. Anthropometric measurements including height, weight, body mass index, waist and hip circumferences, waist-to-hip ratio, and blood pressure were recorded. Insulin resistance was measured by homeostasis model assessment (HOMA). Fasting serum resistin, insulin and plasma glucose, lipid profiles, and uric acid levels were measured. The results revealed that serum resistin level did not correlate with any markers for adiposity, blood pressure, fasting plasma glucose, or uric acid level for either sex. Serum resistin level correlated negatively with fasting insulin level (gamma=-0.455, P=.006) and HOMA (gamma=-0.455, P=.006) in women but not in men. Serum resistin level only correlated negatively with high-density lipoprotein cholesterol (HDL-C) level in men (gamma=-0.347, P=.038); there was no correlation between serum resistin level and lipid profiles in women. Multiple linear regression analysis using the logarithm of resistin as a dependent variable revealed that only HDL-C level (beta=-.058, P=.019) was an independent significant predictor for resistin in men; however, the analysis revealed that HDL-C level (beta=-.044, P=.029) and HOMA (beta=-.719, P=.004) were independent significant predictors for resistin in women. In conclusion, resistin is not related to adiposity, blood pressure, insulin resistance, fasting plasma glucose level, and most lipid profiles. Resistin correlates negatively with HDL-C level for both sexes. The role of resistin in metabolic syndrome warrants further investigation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15798953     DOI: 10.1016/j.metabol.2004.10.015

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  15 in total

1.  Adipokines are associated with lower extremity venous disease: the San Diego population study.

Authors:  M A Allison; M Cushman; P W Callas; J O Denenberg; N E Jensky; M H Criqui
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

2.  Downregulation of leptin and resistin expression in blood following bariatric surgery.

Authors:  Claire Edwards; A Katharine Hindle; Sidney Fu; Fredrick Brody
Journal:  Surg Endosc       Date:  2010-12-22       Impact factor: 4.584

3.  Adipokines and the insulin resistance syndrome in familial partial lipodystrophy caused by a mutation in lamin A/C.

Authors:  S P Y Wong; M Huda; P English; A Bargiota; J P H Wilding; A Johnson; R Corrall; J H Pinkney
Journal:  Diabetologia       Date:  2005-11-17       Impact factor: 10.122

Review 4.  Adipokines and insulin resistance.

Authors:  Katja Rabe; Michael Lehrke; Klaus G Parhofer; Uli C Broedl
Journal:  Mol Med       Date:  2008-09-17       Impact factor: 6.354

5.  Relationship of adipokines and non-esterified fatty acid to the insulin resistance in non-diabetic individuals.

Authors:  A Peti; A Juhasz; P Kenyeres; Z Varga; I Seres; G L Kovacs; G Paragh; L Bajnok
Journal:  J Endocrinol Invest       Date:  2010-04-30       Impact factor: 4.256

6.  Association of resistin polymorphisms with resistin levels and lipid profile in children.

Authors:  Lorena Ortega; Pilar Navarro; Pía Riestra; Teresa Gavela-Pérez; Leandro Soriano-Guillén; Carmen Garcés
Journal:  Mol Biol Rep       Date:  2014-08-06       Impact factor: 2.316

7.  Serum adiponectin and resistin levels in de novo and relapsed acute lymphoblastic leukemia children patients.

Authors:  Hatim A El-Baz; Tamer E Mosa; Elham M Elabd; Amal Ramadan; Ahmed S Elharoun; Elsayed A Elmorsy; Manal I Fouda
Journal:  Iran J Public Health       Date:  2013-05-01       Impact factor: 1.429

8.  Association of circulating resistin with metabolic risk factors in Indian females having metabolic syndrome.

Authors:  V Gupta; A K Singh; Vani Gupta; S Kumar; N Srivastava; T Jafar; A B Pant
Journal:  Toxicol Int       Date:  2011-07

9.  Inflammatory induction of human resistin causes insulin resistance in endotoxemic mice.

Authors:  Hyeong-Kyu Park; Mohammed Qatanani; Erika R Briggs; Rexford S Ahima; Mitchell A Lazar
Journal:  Diabetes       Date:  2011-01-31       Impact factor: 9.461

10.  Circulating levels of WISP-1 (Wnt1-inducible signaling pathway protein 1) and other selected adipokines in children with inflammatory bowel disease.

Authors:  E Karásková; V Kubickova; M Velganova-Veghova; M Geryk; H Foltenova; D Karasek
Journal:  Physiol Res       Date:  2022-04-11       Impact factor: 2.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.